Status:
COMPLETED
Safety Study of ECO Conversion System For Red Blood Cells.
Lead Sponsor:
Velico Medical
Conditions:
Anemia
Eligibility:
All Genders
18-65 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to demonstrate that small amounts of a person's own red cells, when treated with an enzyme to make A-ECO Red Blood Cells, can be safely re-infused, repeatedly. Each partic...
Detailed Description
This study will involve a statistically valid number of subjects so that firm conclusions may be drawn about the safety of small volumes of A-ECO cells. All participants will receive their own (autolo...
Eligibility Criteria
Inclusion
- Healthy volunteer subjects who have no clinically apparent cardiovascular, renal, pulmonary, endocrinological, autoimmune or neurological disorders
- Blood Group A
- Available for follow up periodically at varying intervals for twelve weeks
- Have a clinical presumption of a stable blood volume
- Between 18 and 65 years of age
- Able to provide informed consent
- Practicing contraception, other than oral or systemically delivered contraceptives, while participating in the study (subjects of potential reproductive age).
Exclusion
- Women that are pregnant
- Persons with documented immune deficiencies
- Persons found to have abnormal platelet function or anti-platelet antibodies as determined by a pre-study screen
- Persons with a history of idiopathic thrombocytopenic purpura
- Persons who are bleeding or undergoing an active hemolytic process
- Persons who have any history of hemorrhagic tendency
- Persons who are taking any drug known to interfere with hemostasis, or who take combinations of drugs that have been reported to cause hemostatic problems or interfere with laboratory coagulation and platelet function testing
- Persons who test positive for von Willebrand's disease
- Persons taking investigational drugs or using an investigational device
- Persons with a family history of a bleeding disorder
- Persons with a history of vasculitis
- Persons with a history of a dermatological disorder that might be confused with bruising in the judgement of the investigator
- Persons with medical conditions which represent a contraindication to any study procedure, in the judgement of the investigator
- Persons with unexplained bruising
- Persons with abnormal laboratory screening tests
Key Trial Info
Start Date :
November 1 2005
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00261274
Start Date
November 1 2005
Last Update
May 27 2020
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Yale New Haven Hospital
New Haven, Connecticut, United States, 06510-3202
2
University of Minnesota
Minneapolis, Minnesota, United States, 55455
3
TriCore Reference Laboratories
Albuquerque, New Mexico, United States, 87102
4
Hoxworth Blood Center
Cincinnati, Ohio, United States, 45267-0055